PetMed Express Inc (PETS)
4.70
-0.37
(-7.30%)
USD |
NASDAQ |
Nov 15, 16:00
4.93
+0.23
(+4.89%)
After-Hours: 20:00
PetMed Express Revenue (Annual): 281.06M for March 31, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
March 31, 2024 | 281.06M |
March 31, 2023 | 256.58M |
March 31, 2022 | 272.28M |
March 31, 2021 | 303.58M |
March 31, 2020 | 284.12M |
March 31, 2019 | 283.42M |
March 31, 2018 | 273.80M |
March 31, 2017 | 249.18M |
March 31, 2016 | 234.68M |
March 31, 2015 | 229.40M |
March 31, 2014 | 233.39M |
March 31, 2013 | 227.83M |
March 31, 2012 | 238.25M |
Date | Value |
---|---|
March 31, 2011 | 231.64M |
March 31, 2010 | 238.27M |
March 31, 2009 | 219.41M |
March 31, 2008 | 188.34M |
March 31, 2007 | 162.25M |
March 31, 2006 | 137.58M |
March 31, 2005 | 108.36M |
March 31, 2004 | 93.99M |
March 31, 2003 | 54.97M |
March 31, 2002 | 32.03M |
March 31, 2001 | 10.01M |
March 31, 2000 | 14.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
256.58M
Minimum
2023
303.58M
Maximum
2021
279.53M
Average
281.06M
Median
2024
Revenue (Annual) Benchmarks
TruBridge Inc | 339.44M |
Streamline Health Solutions Inc | 22.60M |
R1 RCM Inc | 2.254B |
LENZ Therapeutics Inc | 15.00M |
Oruka Therapeutics Inc | -- |